{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:35:10Z","timestamp":1794483310135,"version":"4.9.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2025ZD01904100"],"award-info":[{"award-number":["2025ZD01904100"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.isci.2026.117795","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:18:08Z","timestamp":1791580688000},"page":"117795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bispecific antibodies targeting TL1A and IL-12\/23p40 suppress pathogenic Th1\/Th17 responses and ameliorate colitis in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Xia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6057-1097","authenticated-orcid":false,"given":"Feng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117795_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","article-title":"Immunopathology of inflammatory bowel disease","volume":"20","author":"Wallace","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.isci.2026.117795_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2026.117795_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG Clinical Guideline: Management of Crohn's Disease in Adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.isci.2026.117795_bib4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical Guideline: Ulcerative Colitis in Adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.isci.2026.117795_bib5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/gutjnl-2024-332504","article-title":"Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD","volume":"74","author":"Bamias","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.117795_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115017","article-title":"TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential","volume":"26","author":"Tettoni","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117795_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0006-2952(02)01612-X","article-title":"Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT","volume":"65","author":"Wroblewski","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2026.117795_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ibd.21124","article-title":"TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease","volume":"16","author":"Kamada","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.isci.2026.117795_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-065X.2011.01068.x","article-title":"TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation","volume":"244","author":"Meylan","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.isci.2026.117795_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/mi.2010.70","article-title":"Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia","volume":"4","author":"Taraban","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.isci.2026.117795_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dld.2011.09.002","article-title":"Differential expression of the TL1A\/DcR3 system of TNF\/TNFR-like proteins in large vs. small intestinal Crohn's disease","volume":"44","author":"Bamias","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.isci.2026.117795_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2008.04.021","article-title":"The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases","volume":"29","author":"Meylan","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.117795_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/mi.2011.20","article-title":"The tale of TL1A in inflammation","volume":"4","author":"Hsu","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.isci.2026.117795_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.medj.2024.03.010","article-title":"TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis","volume":"5","author":"Solitano","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.isci.2026.117795_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102184","article-title":"IL-12 and IL-23-Close Relatives with Structural Homologies but Distinct Immunological Functions","volume":"9","author":"Floss","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.117795_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.117795_bib17","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.4049\/jimmunol.172.11.7002","article-title":"TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells","volume":"172","author":"Papadakis","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.117795_bib18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.274.5289.990","article-title":"Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95","volume":"274","author":"Chinnaiyan","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.117795_bib19","doi-asserted-by":"crossref","first-page":"39251","DOI":"10.1074\/jbc.M305833200","article-title":"TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells","volume":"278","author":"Wen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.117795_bib20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117795_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.117795_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/07853890.2011.577093","article-title":"Interleukin-23: a key cytokine in inflammatory diseases","volume":"43","author":"Duvallet","year":"2011","journal-title":"Ann. Med."},{"key":"10.1016\/j.isci.2026.117795_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117795_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.117795_bib25","doi-asserted-by":"crossref","first-page":"23514","DOI":"10.1074\/jbc.M604292200","article-title":"Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)","volume":"281","author":"Dall'Acqua","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.117795_bib26","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/j.gastro.2025.01.004","article-title":"Gut Microbiome Signature in Predisease Phase of Inflammatory Bowel Disease: Prediction to Pathogenesis to Prevention","volume":"168","author":"Turpin","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.117795_bib27","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2021.06.011","article-title":"Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study","volume":"19","author":"Danese","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2026.117795_bib28","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","article-title":"Ustekinumab induction and maintenance therapy in refractory Crohn's disease","volume":"367","author":"Sandborn","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117795_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/mi.2012.102","article-title":"Host-dependent control of early regulatory and effector T-cell differentiation underlies the genetic susceptibility of RAG2-deficient mouse strains to transfer colitis","volume":"6","author":"Valatas","year":"2013","journal-title":"Mucosal Immunol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226031767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226031767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:38:24Z","timestamp":1794479904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226031767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2589004226031767"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117795","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bispecific antibodies targeting TL1A and IL-12\/23p40 suppress pathogenic Th1\/Th17 responses and ameliorate colitis in mice","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117795"}}